By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The Nordic EMBL Partnership for Molecular Medicine has officially inaugurated the Institute for Molecular Medicine Finland, or FIMM, a joint research institute operated by the University of Helsinki in collaboration with the Hospital District of Helsinki and Uusimaa, or HUS; the National Institute for Health and Welfare; and the VTT Technical Research Centre of Finland.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.